Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NGENF NervGen Gets IndependentStudy Showing 65%RepairOfStrokeDamage+29%OnNews
This is the most beneficial and best investment potential drug have heard of in 21st century, NVG-291 by NervGen.
The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no FDA-approved drug for the repair of damage from a stroke NVG-291, currently in a Phase 1 clinical trial in healthy human subjects, could provide a completely new treatment paradigm for stroke patients
On the Maze test it showed repair of 65% of the damage from the strokes even though used 7 days after the stroke. Here is chart of that in study:
https://preview.redd.it/dpobefwovde91.png?width=936&format=png&auto=webp&s=863515e6b84dfbeae0b1383e13bbbe416c3d58e6
VANCOUVER, British Columbia--(BUSINESS WIRE)-- NervGen Pharma Corp.(NGENF), , is pleased to announce the University of Cincinnati and Case Western Reserve University (CWRU) have published a pioneering preclinical study in the peer-reviewed scientific journal Cell Reports demonstrating that NervGen’s proprietary drug, NVG-291-R, promotes nervous system repair and significant functional recovery in a mouse model of severe ischemic stroke, even when treatment was initiated up to 7 days after onset. Currently there are no United States Food and Drug Administration (FDA) approved drugs that repair damage from a stroke. NervGen holds the exclusive worldwide rights to NVG-291, which is currently in a Phase 1 clinical trial in healthy human subjects and is preparing to initiate Phase 1b/2 clinical trials for the repair of nervous system damage from spinal cord injury, Alzheimer’s disease and multiple sclerosis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727006174/en/
“We are very excited about the data showing significant improvement in motor function, sensory function, spatial learning, and memory, even when treatment was initiated as late as 7 days after stroke onset,” stated the senior author of the paper, Dr. Agnes (Yu) Luo, Associate Professor, Department of Molecular Genetics and Biochemistry at the University of Cincinnati. “If these results translate to the clinic, NVG-291 would be a substantial breakthrough in the treatment of stroke patients for multiple reasons because the only current FDA-approved drug for treatment of stroke does not repair damage and must be administered within 4.5 hours of stroke onset.” Dr. Luo continued, “Most therapies being researched today primarily focus on reducing the early damage from stroke. However, we have shown that treatment with NVG-291-R not only results in neuroprotection to reduce neuronal death but also robust neuroreparative effects.
Here is the full study: https://www.cell.com/cell-reports/fulltext/S2211-1247(22)00946-9
The market cap is only $100 million, so as BioPub has said this stock can 100 bag. Phase 2 FDA study starts in Q4, that is tests on humans for effectiveness. It is already in Phase 1 for safety on humans and has done well so far. The stock is unknown but with 29% gain yesterday may be getting discovered. Here is an article on the other studies, it includes videos of paralyzed rats regaining the ability to walk in 21 days.
Here is an article on NervGen that covers all the diseases it has studies showing improvement on.
https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth
NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?
$NGENF NervGen Gets IndependentStudy Showing 65%RepairOfStrokeDamage+29%OnNews
This is the most beneficial and best investment potential drug have heard of in 21st century, NVG-291 by NervGen.
The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no FDA-approved drug for the repair of damage from a stroke NVG-291, currently in a Phase 1 clinical trial in healthy human subjects, could provide a completely new treatment paradigm for stroke patients
On the Maze test it showed repair of 65% of the damage from the strokes even though used 7 days after the stroke. Here is chart of that in study:
https://preview.redd.it/dpobefwovde91.png?width=936&format=png&auto=webp&s=863515e6b84dfbeae0b1383e13bbbe416c3d58e6
VANCOUVER, British Columbia--(BUSINESS WIRE)-- NervGen Pharma Corp.(NGENF), , is pleased to announce the University of Cincinnati and Case Western Reserve University (CWRU) have published a pioneering preclinical study in the peer-reviewed scientific journal Cell Reports demonstrating that NervGen’s proprietary drug, NVG-291-R, promotes nervous system repair and significant functional recovery in a mouse model of severe ischemic stroke, even when treatment was initiated up to 7 days after onset. Currently there are no United States Food and Drug Administration (FDA) approved drugs that repair damage from a stroke. NervGen holds the exclusive worldwide rights to NVG-291, which is currently in a Phase 1 clinical trial in healthy human subjects and is preparing to initiate Phase 1b/2 clinical trials for the repair of nervous system damage from spinal cord injury, Alzheimer’s disease and multiple sclerosis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727006174/en/
“We are very excited about the data showing significant improvement in motor function, sensory function, spatial learning, and memory, even when treatment was initiated as late as 7 days after stroke onset,” stated the senior author of the paper, Dr. Agnes (Yu) Luo, Associate Professor, Department of Molecular Genetics and Biochemistry at the University of Cincinnati. “If these results translate to the clinic, NVG-291 would be a substantial breakthrough in the treatment of stroke patients for multiple reasons because the only current FDA-approved drug for treatment of stroke does not repair damage and must be administered within 4.5 hours of stroke onset.” Dr. Luo continued, “Most therapies being researched today primarily focus on reducing the early damage from stroke. However, we have shown that treatment with NVG-291-R not only results in neuroprotection to reduce neuronal death but also robust neuroreparative effects.
Here is the full study: https://www.cell.com/cell-reports/fulltext/S2211-1247(22)00946-9
The market cap is only $100 million, so as BioPub has said this stock can 100 bag. Phase 2 FDA study starts in Q4, that is tests on humans for effectiveness. It is already in Phase 1 for safety on humans and has done well so far. The stock is unknown but with 29% gain yesterday may be getting discovered. Here is an article on the other studies, it includes videos of paralyzed rats regaining the ability to walk in 21 days.
Here is an article on NervGen that covers all the diseases it has studies showing improvement on.
https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth
NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?
What Market is missing about GCM?,it is selling for less that forward annual profits.
And in last week they have bot near $1 million of their own stock.
I bot more today. https://imgur.com/a/vIZ1BjC
What Market is missing about GCM?,it is selling for less that forward annual profits.
And in last week they have bot near $1 million of their own stock.
I bot more today. https://imgur.com/a/vIZ1BjC
My 3 Year CAGR is 97%, 20.25 YearIs23.86%-HowYouCanDoItToo
Many people on iHub chase worthless stock either out of business for years or losing money so bad they will go out of biz, WHY? I have seen it here for years.
If you buy a stock (company) that has 20% or 30% or 40% annual profits or EBITDA yield you get a built-in 20% or 30% or 40% edge each year. That is what I do, most stocks I invest in have those type of yields and I often get 5 baggers, 10 baggers or better. Right now have a 30+ bagger in Petrus and a 20+ bagger in TGA. You can see my broker statements that back up my profit claims above in title on this post, in the below article.
Have written up a stock with a setup to 10 bag, Globex.
Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
It has an EV/EBITDA yield over 60%. Here is how the article starts:
Summary: Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
This video of interview of CEO explains how the company operates:
My 3 Year CAGR is 97%, 20.25 YearIs23.86%-HowYouCanDoItToo
Many people on iHub chase worthless stock either out of business for years or losing money so bad they will go out of biz, WHY? I have seen it here for years.
If you buy a stock (company) that has 20% or 30% or 40% annual profits or EBITDA yield you get a built-in 20% or 30% or 40% edge each year. That is what I do, most stocks I invest in have those type of yields and I often get 5 baggers, 10 baggers or better. Right now have a 30+ bagger in Petrus and a 20+ bagger in TGA. You can see my broker statements that back up my profit claims above in title on this post, in the below article.
Have written up a stock with a setup to 10 bag, Globex.
Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
It has an EV/EBITDA yield over 60%. Here is how the article starts:
Summary: Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
This video of interview of CEO explains how the company operates:
NY Bob, you have been in this a while. Drop by the article and post. https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle Love to see you there, it is free.
Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
NYBob, iGlobex is a gem. On just Mangenese deal they would get $250 million when it is built.
$GLBXF-Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
This is an article wrote Thursday that is on CEO.CA . It is one of the best value stocks have ever seen. Like iHub CEO is free to read and post on. Here is how article starts:
Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
$GLBXF My 3 year CAGRis97%,you can DoSame
Most people get into overvalued stocks and lose money. My Roth IRA has 16 bagged in last 3 years. It was not one stock, have over 50 in that account. You can see my statements in the link below.
I do it with stocks like Globex, gobs of cash, big profits and low valuation.
I just wrote an article on Globex here https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
Please do comment on the article at the bottom. The more exposure the better. GLBXF should 10+ bag in next 2-3 years.
Here is the summation:
Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
Summary
Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
Hot off the press. Article just out on Globex https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
It is mine, on front page now. Please do comment on the article at the bottom. The more exposure the better. GLBXF should 10+ bag in next 2-3 years. Spread it around on other sites too.
Here is the summation:
Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
Summary
Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
Source: Dreamstime.com, public domain
Let's start with Globex's valuation metrics and chart.
While proofing it, bot more. Sold myself
Hot off the press. Article just out on Globex https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle
It is mine, on front page now. Please do comment on the article at the bottom. The more exposure the better. GLBXF should 10+ bag in next 2-3 years. Spread it around on other sites too.
Here is the summation:
Globex Gets Big Royalties For Free, A Deep Value Stock For The Commodity Super Cycle
Summary
Globex is a mining royalty company and a mine and mining claim wheeler/dealer with high growth, and deep value, and that is in the right place at the right time.
Globex often gets a 3% GMR, or Gross Metal Royalty, not the more normal 1% NSR. Since they sell the properties for a profit, those massive royalties are for free.
A 3% GMR is extremely valuable, if a mine they sell produces $2 billion in sales at a 10% profit ($200 million) Globex will get $60 million or 30% of the profits yet has no risk nor investment. If a client miner sells $2 billion of minerals and loses $50 million, Globex will still make the $60 million in profits.
They have over 200 mining properties and dozens of royalties yet are at a dirt-cheap valuation of Allen EV/EBITDA of 1.55, ROCE of 1,926%, Current Ratio of 131 and with Sales Growth of 335%.
Due to having so many deals in place Globex will be a legitimate drilling results news machine on steroids. They pay nothing for the drilling yet benefit greatly when results are good. If 15 clients drill in a year Globex gets the news flow from all of them.
There is only one other deep-value company I know of that gets mining royalties for free. That is GoldSpot. I have a large position in both and think both are outstanding investments.
Globex has high insider ownership and a long record of avoiding dilution and wasteful spending.
Source: Dreamstime.com, public domain
Let's start with Globex's valuation metrics and chart.
While proofing it, bot more. Sold myself
Hot off the press. Article just out on Globex https://ceo.ca/@geodan/globex-gets-big-royalties-for-free-a-deep-value-stock-for-the-commodity-super-cycle It is mine, on front page now. Please do comment on the article at the bottom. The more exposure the better. GLBXF should 10+ bag in next 2-3 years. Spread it around on other sites too.
While proofing it, bot more. Sold myself
Bob it is a natural news machine,Clients Drilling, and they do not have to pay for drilling
3/4th thru
One reason NervGen has not taken off more is that it has greatly outperformed the sector, but the sector is way down in hyper crash. The BBC drug trials ETF is down 52% in last year while NGENF is up 33%, a 85% outperform.
Chartmaster Carter Worth says the biggest predictor of future outperformance is current outperformance.
Here is a compare chart of the two. https://imgur.com/a/EF440mZ
Hi DewDiligence, It is Canadian and have found them to be as reliable as US on books. It is a Canadian Pink mirror stock. I have over a dozen of them and many have revenue over $500 million. And have done very well on them.
However this year NervGen will go NASDAQ, it will cost them near $5 million to do that. But think it is a good idea. I never buy Pinks that have no SEC books that are American companies.
Think there are myths about size = safety. The stocks I went short on about 3 weeks ago via options are big caps, COST, BYND, UBER, QQQ and DIS and am up on every one, as they are down. My best stock of the last 2 years is Petrus PTRUF a Canada Pink mirror. Have a 40 bagger on them. There was risk on that one, but when the downside is 0 and upside a 40 bagger and odds 50/50 that is a good investment it you do not go too big on it. I tend towards sub 5 EV/EBITDA stocks with growth and find them normally in micro-nano caps. BTW that is how Buffet made his first billion, value nano-micros. They are the safer stocks than the BYND and PTON big caps with terrible value.
I would keep a eye on this for when it goes NASDAQ, best can tell it is the highest potential stock have ever found.
Cheers
NervGen Regenerates Neurons,What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?
I wrote an article today on this subject. Anyone here ever looks at them? I have been very sucessful investing for a long time, 23.86% CAGR over 20.25 years.
It is high potential stocks like this one that have been able to do that with. This company has top notch people in it like Craig Thompson—the former Vice President, Marketing at Pfizer. Also worth noting are the company’s Chief Medical Officer, Dan Mikol, who joined in May 2021 and came from a senior position in Amgen, as well as the world-class clinical advisory boards that the company works with.
Curious if anyone here has even heard of NervGen.
Here is the article wrote: https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth
The first video shows that 50% of rats with severed spinal cords regain walking ability and 75% of MS induced rats regain ability to walk again. They prevent special nerve scar tissue from preventing regrowth. Human Neurons under a microscope regrow in that video too. It is teh most exciting stock have ever found.
Cheers
NYBob I bot more GCM today. It will takeoff, suprised not already twice as high but it is one of those strange outliers. You get the biggest gains normally in the stocks the markets ignores value in the longest.
Off topic I wrote an article CEO which will go on Seeking Alpha when the get their act together. Think it is the highest potential stock have ever seen. Today it and GCM are about tied as my biggest positions:
I published today. This includes videos of both severed spinal cord rats regaining control of read legs, and MS induced rats paralyzed that regained the ability to walk (85% of rats responded). Article published https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth
Article on NervGen is out,https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth
NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?
Summary
NervGen has already regenerated neurons under the microscope and in live rats with severed spinal cords. The rats regained most of the function in paralyzed legs.
The market cap of NervGen is under $80 million. It is currently in Phase 1 FDA trials in humans and is about to go into Phase 2.
NervGen has exclusive rights to the technology from Case Western University. It is backed by top experts in the field and staffed by very high-level pharma executives.
It has no competitors that can repair damage to the nervous system. If it works 50% as well in humans as in animals, a $15 billion market cap is feasible.
I have it on CEO now, it is non exclusive, will put on Seeking Alpha later. Please spread it around. Thanks!
Nick got back to me.Their site is under attack is why down, provider working on it.
He sent me the March 2022 Presentation as a PDF
OVERVIEW OF THE GALAXY MINE
M&I Resources: 970,904 oz Au at average grade of 2.77 g/t Au
Inferred Resources: 1,409,764 oz Au at average grade of 2.62 g/t Au
So grade is way higher than projected grade in last report. He had hinted at this in Dec, that the ore was wider and higher grade than they expected in a video.
Katchum went through the TSX version of 10K, his video is worth watching, link again
Where did this video come from?Excellent.
Twitter from insider,799 million barrels OOIP for one well, 3rd party seismic estimate.
https://twitter.com/Grayson_Anderse/status/1519997114020937739/photo/2
That is a guess, official guess but a guess. If 10% recovered that is 80 million barrels or $8 billion for 1 well. Going to be an excitig next few months
I did not know about Mexico? what is that about?
There is a new Serafino video out there NYBOB
Thanks AndrewDiceClay I bot a lot of STRUF and a happy camper with it.
it is moderately good news. The stock is doing quite well for this market. GFG can win big from 2 seperate things, Goldarm and Rattlesnake.
NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth?
Apr. 23, 2022 7:17 PM ET| About: NervGen Pharma Corp. (NGENF), Includes: KRRGF, PTRUF
Darp Research
Summary
NervGen has already regenerated neurons under the microscope and in live rats with severed spinal cords. The rats regained most of the function in paralyzed legs.
The market cap of NervGen is under $80 million. It is currently in Phase 1 FDA trials in humans and is about to go into Phase 2.
NervGen has exclusive rights to the technology from Case Western University. It is backed by top experts in the field and staffed by very high level pharma executives.
It has no competitors that can repair damage to the nervous system. If it works 50% as well in humans as in animals, a $15 billion market cap is feasible.
It is rare to find drug developer that has an outstanding risk/reward proposition. Most are bad investments that go bankrupt or lose much of their value from my observation. NervGen Phrama, (NGEN.TSX-V)(OTCPK:NGENF) is a big exception to the common overvaluation in this sector.
I have over 75 stocks in my portfolio and NervGen is the only drug company stock in it. The social good possible from their drug is the best have ever seen. Plus the investment potential of the company is also the best have ever seen.
Doing stock research is something I have spent about 25 hours a week doing for the last 20 years. By accident saw a video about them and their drug candidate. After watching the videos below and doing more research on the company, see it as the highest potential stock have ever found.
Here is link to 2 videos in article. It is about 10 pages long, hopefully will be out early next week, awaiting one final proof. I am submitting as an article not a blogpost. That is on SeekingAlpha.
Thanks Clogger
Was going to post this 2 hours ago, had distractions but seems even more clear now. Have said many times that when the big moves take place it is when a big seller/s runs out, goes away. This morn GoldSpot was seeing that. The spread widened, action was mid or on Ask, bid was bigger. Just had that feel the supply of stock was going away. It was about .61 then.
Just checked, now is .6318 up 3.5%, Sounds like nothing but it is a change in trend, a new 5 week high. A sloppy Cup and Handle breakout. Yesterday big volume 300,000 on OTC side. Today? Nada, 16,000 only. Backs up a sellers strike, that the big seller/s having been taken out.
There was no reason for it to be this low, it ignored gold even when it went over over $2,000. But today gold down hard and it makes a 5 week new high. Like it. Hope it is indeed the big irrational seller/s out of the stock.
There is no GoldSpot Seeking article. I co-wrote one here https://ceo.ca/@sustainabedude/goldspot-discoveries-gets-paid-to-receive-mining-royalties-a-revolutionary-business-model
Cheers
$STRFF SeekingAlpha article calls for a 7 Bagger
Laurentian Research You put a lot of work into this, thanks. In the last week Star has been one of my biggest buys. With your excellent articles on Star Royalties STRFF I do not have to write an article, just point people to yours. https://seekingalpha.com/article/4502048-best-stocks-for-esg-investors
You said: "Today, Star Royalties has a market cap of US$60.9 million on a fully-diluted basis, in which the market is clearly yet to give credit to Star Royalties' 61.9% ownership of Green Star Royalties that is valued at C$25 million (or US$19.8 million) by Agnico, C$14.13 (million you missed that) of cash proceeds to be received from Agnico, and C$4.2 million of cash on Star's balance sheet. Star Royalties is thus deeply undervalued and it may potentially deliver a 7-bagger in the next 3 years if the projected revenue growth materializes."
Great summation. There is so much to like about it. They printed money legally with GreenStar just like GoldSpot did with their spinoff. Also have a ton of SPOFF. There are some fantastic videos out on Star. One has The Chief Investment Officer who refuses to get paid and instead bot a bunch of stock, his only reward is to get the stock up. And he is an award winning investor. And another one by CEO where he points out right now the stock should be at least twice what it is.
Cheers
Wrote the below comment on new Seeking Alpha GCM article https://seekingalpha.com/article/4501285-gcm-mining-pre-construction-at-toroparu-has-begun
Good info on Toroparu project. Good to see people writing up GCM more. You have done that multiple times.
I have been in it for 5 years, since it was $1. Today it is far cheaper at $4.66 than it was at $1 in 2017. Back then it was 50/50 they would survive, terrible debt problems plus high ASIC. The execution since then (it is new management) has been spectacular. I spent an hour on phone with Mike Davies back then and was impressed and that is how got in it.
Last month or so have thought that GCM and Galane are the two best value gold miners out there, and not irrationally have made them my 2 biggest positions. Both have ignored progress and the gold price, as Fun's chart shows for GCM.
Both have been held back by a big seller/s, IMHO. Galane's big seller/s went away on Monday and it has gone up 20% since then. I have a writeup on Galane you can not see in articles as it is a blogpost. For those interested in it, here: Buy Profitable And Future 110,000oz Miner Galane Gold For $26.6 Million, Comparison To $316 Million Pure Gold https://seekingalpha.com/instablog/535947-darp-research/5648819-buy-profitable-and-future-110000oz-miner-galane-gold-for-26_6-million-comparison-to-316 Galane has super trounced Pure Gold since then.
Before GCM was likely the best of the two value/safety wise, now with Galane's 50% rise in last month think GCM is clearly the #1 value in gold miners today. It would take 20 pages to say why. Why is it not 2 or 3 or 4 times higher today than it is?
My guess is that big seller/s whether from a prior deal or whatever. Karora had the same problem, but in the last 2 years since Covid bottom it is up over a 7 bagger. It was in Oct 2021 that the irrational selling of Karora went away and it has soared since.
Have noticed the biggest and fastest rallies often happen when a big seller that prevents a stock from rising goes away, when they run out of stock. That has not happened for GCM yet. But any day it can. And when that happens a 50% rise to $7 could easily happen in 30 days. The current holders are tearing their hair out in frustration. They see GCM as doing everything right, making huge amounts of money in last 2 years, setting themselves up to massively grow, paying a big (for miners) monthly dividend, and buying back lots of stock. Yet the stock is flatlined while gold and other gold stocks are taking off. No doubt wearing some out, causing more selling.
But like Karora and Galane the selling can not last forever. Can no one not see the value in GCM? No, Redcloud said this 3 weeks ago:
Valuation:
We maintain our BUY rating and target price of C$18.00/sh. Our target is based on a 0.9x multiple for Segovia and 0.6x for Toroparu applied to our NAV5% estimate of $25.64/sh (was $26.38). Upcoming Catalysts:
1) Q4/21 financial results and 2022 guidance (Q1/22), 2) annual mineral reserve and resource update (Mar/22) and
3) Toroparu PFS (Q1/22). https://cdn-ceo-ca.s3.amazonaws.com/1h36gbj-20220223-GCM-Update-1.pdf
They are calling for a triple. Most people that buy stocks have zero idea what they are buying. They do not know the market cap of the company is, what the free cash flow is, what the debt level is, etc. That is how stocks get so super miss-valued, like Cisco in 2000. That company was good but because most investors have no value anchor they overvalued it so insanely that it has never been that high in the 22 years since, a horrible investment, even though the company is far far bigger and more profitable today.
This creates opportunity for those that can value a company.
GCM now has a EBIT Earnings Yield of 40% before taxes, an Allen EV/EBITDA of 2.20 and a PE of 2.33. Their return on capital employed (ROCE) is 66%. This is just for Segovia, it is ignoring their numerous other assets such as Toroparu which will be a bigger mine than Segovia, their ARIS public stock worth $85 million, and on and on.
It is as absurd a valuation as KRRGF stock was at .65 two years, which is now $5.83, except that GCM has higher growth prospects than Karora did two years ago. Unless there is a liquidity crash there is no reason for GCM to ever see $4 a share again, is how see it.
Cheers
This is big news, thanks BornAgain
.155 up another +9% Looks like sellers ran out of stock, effortless going up.
Cheers
Thanks, had missed that one,NewHigh today
NYBob,video of them working in mine today
New high for year, .14 +7% on GGGOF Galane.
2 15 minutes agoThis Monday's production inspiration: We get a good look at the mining equipment hauling ore directly from the galaxy working face. pic.twitter.com/n3SGKneXyb
— Galane Gold (@GalaneGoldLtd) April 11, 2022
I think 2022 will be great year for them$2+ possible. I bot more in .60s. This reminds me of 2020, good sales followed by big rally
I have been buying Globex GLBXF for a while, started in .90s and more in 1.00-1.05 area. Have been awaiting PQEFF tender to complete to put more it in. Well GLBXF did not wait around it is now $1.29. Fortunately have a lot, but wanted more.
They are a used mine/claim wheeler dealer. 100s of mining properties and dozens of royalties yet at a dirt cheap valuation.
Like GoldSpot they can not lose, either make money just selling claims, or if a customer hits a rich deposit Globex then gets a lot more cash and GLBX gets a royalty on it too. Big royalties, usually 3% Gross Metal not more normal 1% NSR, so no matter what type of metal it is they get paid. They started with practically nothing. Jack Stoch has run it from beginning.
Now for the first time GLBXF has a bundle of cash. $24 million last looked, and even after 30% gain the mkt cap is only $70 million. No debt and they tout how they have avoided dilution for many years. He wants to go big now that has cash.
EV/EBITDA of 2.9 and PE under 5, but check this out. UncleStock says CROIC is 627% and ROCE is 2,940% maybe the highest combo of any stock in the world. It is a fantastic business model. It has taken decades to build it up to this point where the payback comes. In video below Jack explains Globex.
Was keeping quiet to get money to buy more but being it is taking off with new highs now, decided to share it. One more thing, they do so many deals and have so many properties being drilled, that they are a constant source of real news.
I have been buying Globex $GLBXF for a while, started in .90s and more in 1.00-1.05 area. Have been awaiting PQEFF tender to complete to put more it in. Well GLBXF did not wait around it is now $1.29. Fortunately have a lot, but wanted more.
They are a used mine/claim wheeler dealer. 100s of mining properties and dozens of royalties yet at a dirt cheap valuation.
Like GoldSpot they can not lose, either make money just selling claims, or if a customer hits a rich deposit Globex then gets a lot more cash and GLBX gets a royalty on it too. Big royalties, usually 3% Gross Metal not more normal 1% NSR, so no matter what type of metal it is they get paid. They started with practically nothing. Jack Stoch has run it from beginning.
Now for the first time GLBXF has a bundle of cash. $24 million last looked, and even after 30% gain the mkt cap is only $70 million. No debt and they tout how they have avoided dilution for many years. He wants to go big now that has cash.
EV/EBITDA of 2.9 and PE under 5, but check this out. UncleStock says CROIC is 627% and ROCE is 2,940% maybe the highest combo of any stock in the world. It is a fantastic business model. It has taken decades to build it up to this point where the payback comes. In video below Jack explains Globex.
Was keeping quiet to get money to buy more but being it is taking off with new highs now, decided to share it. One more thing, they do so many deals and have so many properties being drilled, that they are a constant source of real news.